COVID-19: China approves two vaccines for clinical trials

COVID-19: China approves two vaccines for clinical trials

COVID-19: China approves two vaccines for clinical trials

"But as this is an isolated report this doesn't necessarily mean vaccine attempts are futile". We believe these efforts will help reduce inefficiencies and duplication of effort, and we will work tenaciously to increase the likelihood that one or more safe and effective vaccines will soon be made available to all.

In the global race to produce vaccines for the novel coronavirus, China has launched human trials on two more potential candidates. This type of vaccine is new but promising.

An adenovirus (common virus) vector vaccine, developed by a research team led by Major General Chen Wei of the Institute of Military Medicine under the Academy of Military Sciences of the People's Liberation Army, was the first to be approved to enter clinical trial.

"A vaccine is the only clear exit strategy that will allow New Zealand to return to normality".

The group also raised concerns about whether vaccines could be hoarded behind a single supplier and whether countries might close off pharmaceutical exports.

Measles immunization campaigns in 24 countries have already been delayed, and more will be postponed, potentially putting children in 37 countries at risk, according to the Measles & Rubella Initiative (M&RI), which is backed by the World Health Organization, the United Nations children's fund UNICEF and others.

Another vaccine, being developed by the Wuhan Institute of Biological Products and the Wuhan Institute of Virology, was approved on Sunday, he added.

The drug industry is hoping to shorten the time it takes to get a vaccine to market - usually about 10 to 15 years - to within the next year.

A programme would cost tens of millions of dollars in the early stages but that was "chicken feed" compared to the cost of the current lockdown. While new drugs are being developed, companies are also seeing if older drugs can be repurposed.

On Monday, the World Health Organization (WHO) said a group of experts with diverse backgrounds was working towards the development of vaccines against COVID-19 and it seems like China may have already found what could potentially be the cure to the deadly virus.

As the elderly make up a high percentage of the severely ill COVID-19 patients, the vaccine should build a safety shield for them, Chen said.

Related news

[an error occurred while processing the directive]